The support chapter lists £200 million for medical equipment and £920 million for business modernization of support. Specific medical lines include £20 million for tactical combat casualty-care kits and £10 million for field-hospital equipment. It also describes £10 million for dried blood products and £10 million for treatment intended to reduce blood loss. Another £50 million covers critical support information systems and hardware. These examples show what some allocations would buy, but the much larger £920 million modernization sum has no similarly clear explanation in the discussion.
Chapter · 5:10:21-5:12:06
Medical support lists specific purchases while a larger modernization line stays unclear
Combat medical purchases have named purposes, while the £920 million support-modernization allocation lacks a comparable explanation.